Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...
There is broad consensus that widespread SARS-CoV-2 testing is essential to safely reopening the United States. A big concern has been test availability, but test accuracy may prove a larger long-term ...
A research team from three Johns Hopkins institutions has shown that SARS-CoV-2, the virus that causes COVID-19, can “reprogram” pathogen-fighting white blood cells known as neutrophils (left side) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results